A. Stephens

Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Volker A Erdmann, Jens Kurreck, Matthias Friebe, 2004, Nucleic acids research.

Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.

G. Hutchins, L. Einhorn, G. Hutchins, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequence variation in heparin octasaccharides with high affinity for antithrombin III.

D. Atha, R. Rosenberg, A. Rimon, 1984, Biochemistry.

Evaluation of critical groups required for the binding of heparin to antithrombin.

D. Atha, R. Rosenberg, A. Stephens, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Kinetic Characterization of the Proteinase Binding Defect in a Reactive Site Variant of the Serpin, Antithrombin

S. Olson, I. Björk, P. E. Bock, 1995, The Journal of Biological Chemistry.

Expression of functionally active human antithrombin III.

A. Stephens, C. Hirs, A. Siddiqui, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III.

A. Stephens, C. Hirs, A. Siddiqui, 1988, The Journal of biological chemistry.

Antithrombin-III Denver, a reactive site variant.

B. Thalley, A. Stephens, C. Hirs, 1987, The Journal of biological chemistry.

Tumor targeting by an aptamer.

Ying-Fon Chang, B. Hicke, Jim Heil, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Escort aptamers: a delivery service for diagnosis and therapy.

B. Hicke, A. Stephens, Brian J. Hicke, 2000, The Journal of clinical investigation.

In vivo Thrombosis Imaging in Patients Recovering from COVID-19 and Pulmonary Embolism.

E. V. van Beek, M. Dweck, D. Newby, 2021, American journal of respiratory and critical care medicine.